Literature DB >> 8432015

Homocysteine and other thiols in plasma and urine: automated determination and sample stability.

T Fiskerstrand1, H Refsum, G Kvalheim, P M Ueland.   

Abstract

We have developed a modified version of our fully automated column-switching HPLC method for determining total plasma homocysteine based on single-column (reversed-phase) separation. Homocysteine, cysteine, and cysteinylglycine in plasma (total concentrations), acid-precipitated plasma (non-protein-bound concentrations), and urine can be determined. The derivatization and chromatography were performed automatically by a sample processor. The successful separation of all thiol species (within 15 min) was accomplished by accurate adjustment of the pH of the mobile phase to 3.65 (plasma) or 3.50 (acid-precipitated plasma, urine). Maximal fluorescence yield of cysteine, cysteinylglycine, and, to a lesser degree, homocysteine was dependent on optimal concentrations of EDTA and dithioerythritol during reduction (with NaBH4) and derivatization (with monobromobimane). The method is sensitive (detection limit approximately 0.05 pmol) and has a high degree of precision (CV < 5%). The sample output is approximately 70 samples in 24 h. Serum and heparin plasma can also be analyzed. Hemolysis up to approximately 2.0 g/L of hemoglobin did not interfere with the analytical recovery of homocysteine or cysteine. Collection of blood, separation of plasma from whole blood, and acid precipitation must be standardized to obtain reproducible thiol results. Our modifications and the standardization of blood-sampling procedures have substantially improved the method and broadened its applications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432015

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  39 in total

1.  Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease.

Authors:  M Cahill; M Karabatzaki; R Meleady; H Refsum; P Ueland; D Shields; D Mooney; I Graham
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 2.  Stability of IgG isotypes in serum.

Authors:  Ivan R Correia
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

3.  Functional inference of the methylenetetrahydrofolate reductase 677C > T and 1298A > C polymorphisms from a large-scale epidemiological study.

Authors:  Arve Ulvik; Per M Ueland; Ase Fredriksen; Klaus Meyer; Stein Emil Vollset; Geir Hoff; Jørn Schneede
Journal:  Hum Genet       Date:  2006-11-18       Impact factor: 4.132

4.  Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.

Authors:  A B Guttormsen; P M Ueland; I Nesthus; O Nygård; J Schneede; S E Vollset; H Refsum
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 5.  ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.

Authors:  R A Still; I F McDowell
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

Review 6.  Assessment of homocysteine status.

Authors:  H Refsum; T Fiskerstrand; A B Guttormsen; P M Ueland
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

7.  Detection of homocysteine and cysteine.

Authors:  Weihua Wang; Oleksandr Rusin; Xiangyang Xu; Kyu Kwang Kim; Jorge O Escobedo; Sayo O Fakayode; Kristin A Fletcher; Mark Lowry; Corin M Schowalter; Candace M Lawrence; Frank R Fronczek; Isiah M Warner; Robert M Strongin
Journal:  J Am Chem Soc       Date:  2005-11-16       Impact factor: 15.419

8.  Prospective study of plasma homocysteine, its dietary determinants, and risk of age-related macular degeneration in men.

Authors:  William G Christen; Nancy R Cook; Stephanie E Chiuve; Paul M Ridker; J Michael Gaziano
Journal:  Ophthalmic Epidemiol       Date:  2017-10-16       Impact factor: 1.648

9.  Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents.

Authors:  Rosalie A M Dhonukshe-Rutten; Marijke van Dusseldorp; Jörn Schneede; Lisette C P G M de Groot; Wija A van Staveren
Journal:  Eur J Nutr       Date:  2004-08-30       Impact factor: 5.614

10.  Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts.

Authors:  E H Stet; R A De Abreu; J P Bökkerink; H J Blom; L H Lambooy; T M Vogels-Mentink; A C de Graaf-Hess; B van Raay-Selten; F J Trijbels
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.